Ramezani Mohammad Arash, Ahmadi Khodabakhsh, Ghaemmaghami Afagh, Marzabadi Esfandiar Azad, Pardakhti Faezeh
Department of Sexual Health, Behavioral Sciences Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Department of Sexual Health, Behavioral Sciences Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran ; Department of Counseling, Islamic Azad University, Marvdasht Branch, Marvdasht, Iran.
Int J Prev Med. 2015 May 20;6:43. doi: 10.4103/2008-7802.157472. eCollection 2015.
The aim of this study was to determine the cumulative prevalence rate of every sexual dysfunctions (SDs) in Iranian population.
We searched international database such as: PubMed/Medline, Scopus, PsychNET, and Scholar Google and Iranian database such as Iran Psych, IranDoc, IranMedex, and SID. Search duration was between 1990 and 2013.
From 449 articles were retrieved, then 11 articles on male with total sample size of 2142 and 8 articles on female with total sample size of 4391 were selected after critical appraisal. For quality assessment check list to evaluate a prevalence article was contained study population, sampling method, sample size, criteria for SD diagnosis, specific rates, study location, and authors list. In male, erectile dysfunction was 56.1%. In female, pooled estimation prevalence of hypoactive sexual desire disorder in complained group was 65.8% (95% confidence interval [CI]: 51.1-80.6%) compared to general population 35% (95% CI: 17.6-52.1%). Sexual arousal disorder in clinical patient was 59.6% (95% CI: 39-80%) against 33.8% (95% CI: 18.3-49.3%) in general population. Orgasmic disorder in complained was 35.5% (95% CI: 16-55%) and in general population was 35.3% (95% CI: 26.8-43.8%). Sexual pain disorder pooled estimation prevalence were 35.2% (95% CI: 14.5-56%) versus 20.1% (95% CI: 6.4-33.8%) in complained and general population consecutively.
The rate of SD in Iran was approximately the same of worldwide except orgasmic disorder which was two times more than the worldwide average.
本研究旨在确定伊朗人群中各类性功能障碍（SDs）的累积患病率。
我们检索了国际数据库，如：PubMed/Medline、Scopus、PsychNET和谷歌学术，以及伊朗数据库，如Iran Psych、IranDoc、IranMedex和SID。检索时间为1990年至2013年。
从检索到的449篇文章中，经过严格评估后，选取了11篇关于男性的文章，总样本量为2142，以及8篇关于女性的文章，总样本量为4391。用于评估患病率文章的质量评估清单包含研究人群、抽样方法、样本量、性功能障碍诊断标准、特定比率、研究地点和作者名单。在男性中，勃起功能障碍的患病率为56.1%。在女性中，主诉组性欲减退障碍的合并估计患病率为65.8%（95%置信区间[CI]：51.1 - 80.6%），而一般人群为35%（95% CI：17.6 - 52.1%）。临床患者性唤起障碍的患病率为59.6%（95% CI：39 - 80%），而一般人群为33.8%（95% CI：18.3 - 49.3%）。主诉组性高潮障碍的患病率为35.5%（95% CI：16 - 55%），一般人群为35.3%（95% CI：26.8 - 43.8%）。性疼痛障碍的合并估计患病率在主诉组和一般人群中分别为35.2%（95% CI：14.5 - 56%）和20.1%（95% CI：6.4 - 33.8%）。
伊朗性功能障碍的发生率与全球大致相同，除了性高潮障碍，其发生率是全球平均水平的两倍。
